[Comparative studies of sinus floor elevation with autologous or allogeneic bone tissue]

Maxillary sinus augmentation is a widely used procedure to increase bone volume for dental implants. While autografts have long been considered the gold standard due to their osteoinductive properties, they carry risks such as donor site morbidity. Allogeneic bone grafts offer an alternative that avoids these complications. However, the effectiveness of allogeneic grafts compared to autografts remains a topic of debate. Prior research has shown that autografts promote bone regeneration, but their limitations have driven the search for equally effective alternatives. No prior work had resolved whether allogeneic grafts could match autografts in terms of bone formation and implant success. This uncertainty motivated the current study to evaluate the clinical outcomes of autologous versus allogeneic bone grafts in maxillary sinus lifts. The study aimed to determine if allogeneic grafts could provide comparable results while reducing patient discomfort. Understanding the differences in augmentation height and postoperative recovery is essential for optimizing treatment planning.

This study aimed to compare the clinical outcomes of autologous and allogeneic bone grafts in maxillary sinus augmentation procedures. The researchers focused on assessing bone formation, implant success, and postoperative recovery between the two graft types. They wanted to determine if allogeneic grafts could replace autografts in cases where additional alveolar ridge augmentation was not required. The motivation for this comparison stemmed from the known limitations of autografts, such as donor site pain and longer recovery times. The study sought to evaluate whether allogeneic grafts could achieve similar bone quality and implant stability. The researchers also aimed to measure the duration of postoperative discomfort associated with each graft type. By comparing these parameters, the study aimed to inform clinical decision-making in dental implant surgery. The specific problem addressed was the need for a less invasive yet equally effective bone grafting option.

The study involved 63 patients who underwent 82 maxillary sinus elevation procedures. In 39 cases, autografts were harvested from the iliac crest and used for augmentation. In 43 cases, allogeneic bone grafts were used, including AAA bone and DFDBA or Grafton. The researchers monitored bone formation using radiographic and histological analyses. Radiopaque areas were evaluated as indicators of new bone formation. Histological samples were obtained to assess the transformation of graft material into patient bone tissue. The average augmentation height was measured in both groups. Postoperative recovery was tracked through patient-reported discomfort and endoscopic evaluations. Dental implants were placed in the augmented areas, and osseointegration was assessed. The study compared the success rates of implants placed in autograft and allogeneic graft sites. The researchers also documented the duration of postoperative symptoms for each group. These methods allowed for a comprehensive evaluation of graft performance and patient outcomes.

The average augmentation height was 14 mm for autografts and 9 mm for allogeneic grafts. Radiographic analysis showed that allogeneic grafts formed radiopaque areas equivalent to bone. Histological examination confirmed that allogeneic grafts were fully transformed into patient bone tissue. No differences in bone quality were observed between the two graft types. Endoscopic evaluations revealed nonirritated mucous membranes in both groups. A total of 2 implants failed in the autograft group, while 2 implants failed in the allogeneic group. Patients receiving autografts experienced postoperative discomfort for an average of 19 days. Patients with allogeneic grafts had symptoms for an average of 3 days. Thirteen patients with allogeneic grafts were symptom-free within hours of surgery. These results suggest that allogeneic grafts can achieve comparable bone formation and implant success. The shorter recovery time with allogeneic grafts is a notable advantage. The study supports the use of allogeneic grafts in appropriate clinical scenarios.

The authors concluded that allogeneic bone grafts are a viable alternative to autografts for maxillary sinus augmentation. They found that allogeneic grafts achieved similar bone formation and implant success rates. The shorter recovery time with allogeneic grafts is a significant benefit. The study supports the use of allogeneic grafts when additional alveolar ridge augmentation is not required. The authors noted that no differences in bone quality were observed between the two graft types. The endoscopic findings indicated that both graft types were well-tolerated. The researchers emphasized the importance of patient comfort and recovery time in treatment planning. These findings suggest that allogeneic grafts can be considered in appropriate clinical situations.